학술논문
Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults -- United States, August-December 2021.
Document Type
Article
Author
Tenforde, Mark W.; Patel, Manish M.; Gaglani, Manjusha; Ginde, Adit A.; Douin, David J.; Talbot, H. Keipp; Casey, Jonathan D.; Mohr, Nicholas M.; Zepeski, Anne; McNeal, Tresa; Ghamande, Shekhar; Gibbs, Kevin W.; Files, Clark; Hager, David N.; Shehu, Arber; Prekker, Matthew E.; Erickson, Heidi L.; Gong, Michelle N.; Mohamed, Amira; Johnson, Nicholas J.
Source
Subject
Language
ISSN
0149-2195
Abstract
The article informs that for adults aged ≥18 years who received 2 doses of an mRNA COVID-19 vaccine, third doses are recommended. However, the associated benefits in preventing COVID-19 hospitalization are incompletely understood. it is noted that administration of a third COVID-19 mRNA vaccine dose as part of a primary series among immunocompromised adults improved protection against COVID-19–associated hospitalization.